Hrt Financial LP Roivant Sciences Ltd. Transaction History
Hrt Financial LP
- $20.6 Billion
- Q3 2025
A detailed history of Hrt Financial LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Hrt Financial LP holds 486,244 shares of ROIV stock, worth $9.87 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
486,244
Previous 119,775
305.96%
Holding current value
$9.87 Million
Previous $1.35 Million
445.29%
% of portfolio
0.04%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding ROIV
# of Institutions
374Shares Held
436MCall Options Held
6.05MPut Options Held
2.52M-
Morgan Stanley New York, NY44.3MShares$899 Million0.04% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X040.3MShares$818 Million4.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA38.8MShares$787 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$718 Million0.01% of portfolio
-
Qvt Financial LP New York, NY29.4MShares$596 Million36.4% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $14.3B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...